{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T21:47:14Z","timestamp":1779400034231,"version":"3.53.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","geriatriconcology.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jgo.2023.101582","type":"journal-article","created":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T15:50:05Z","timestamp":1688831405000},"page":"101582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prognostic significance of the Geriatric 8 score alone and included with genetic risk group in older adults with acute myeloid leukemia"],"prefix":"10.1016","volume":"14","author":[{"given":"Kei","family":"Fujita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuji","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiju","family":"Negoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Oiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Tsurumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgo.2023.101582_bb0005","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","article-title":"Epidemiology of acute myeloid leukemia: recent progress and enduring challenges","volume":"36","author":"Shallis","year":"2019","journal-title":"Blood Rev"},{"issue":"3","key":"10.1016\/j.jgo.2023.101582_bb0010","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","article-title":"Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials","volume":"116","author":"Grimwade","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jgo.2023.101582_bb0015","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jgo.2023.101582_bb0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-2141.2001.03043.x","article-title":"Prognostic significance of risk group stratification in elderly patients with acute myeloid leukaemia","volume":"115","author":"Wahlin","year":"2001","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.jgo.2023.101582_bb0025","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1200\/JCO.2009.25.8616","article-title":"\u201cI am older, not elderly,\u201d said the patient with acute myeloid leukemia","volume":"28","author":"Schiffer","year":"2010","journal-title":"J Clin Oncol"},{"issue":"24","key":"10.1016\/j.jgo.2023.101582_bb0030","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1200\/JCO.2013.54.8347","article-title":"International society of geriatric oncology consensus on geriatric assessment in older patients with cancer","volume":"32","author":"Wildiers","year":"2014","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.jgo.2023.101582_bb0035","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1182\/blood.2021013671","article-title":"Geriatric assessment predicts nonfatal toxicities and survival for intensively treated older adults with AML","volume":"139","author":"Min","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jgo.2023.101582_bb0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1200\/JCO.2013.51.1345","article-title":"Performance of two geriatric screening tools in older patients with cancer","volume":"32","author":"Kenis","year":"2014","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jgo.2023.101582_bb0045","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/bjh.17554","article-title":"Association of the Geriatric 8 with treatment intensity and prognosis in older patients with diffuse large B-cell lymphoma","volume":"194","author":"Lee","year":"2021","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.jgo.2023.101582_bb0050","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"3","key":"10.1016\/j.jgo.2023.101582_bb0055","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00277-018-3551-y","article-title":"Geriatric screening tools predict survival outcomes in older patients with diffuse large B cell lymphoma","volume":"98","author":"Sakurai","year":"2019","journal-title":"Ann Hematol"},{"issue":"6","key":"10.1016\/j.jgo.2023.101582_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179694","article-title":"The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: a retrospective, single institutional study","volume":"12","author":"Takahashi","year":"2017","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.jgo.2023.101582_bb0065","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s00784-019-03056-y","article-title":"Clinical significance of the G8 screening tool in elderly patients with oral squamous cell carcinoma","volume":"24","author":"Yamada","year":"2020","journal-title":"Clin Oral Investig"},{"issue":"12","key":"10.1016\/j.jgo.2023.101582_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115060","article-title":"Screening for vulnerability in older cancer patients: the ONCODAGE prospective multicenter cohort study","volume":"9","author":"Soubeyran","year":"2014","journal-title":"PloS One"},{"issue":"22","key":"10.1016\/j.jgo.2023.101582_bb0075","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1182\/blood-2010-03-276485","article-title":"Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia","volume":"116","author":"Kantarjian","year":"2010","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jgo.2023.101582_bb0080","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S1470-2045(12)70436-9","article-title":"Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study","volume":"13","author":"Kantarjian","year":"2012","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.jgo.2023.101582_bb0085","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1182\/bloodadvances.2016003053","article-title":"A phase 2 study incorporating sorafenib into the chemotherapy for older adults with FLT3-mutated acute myeloid leukemia: CALGB 11001","volume":"1","author":"Uy","year":"2017","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.jgo.2023.101582_bb0090","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood.V84.9.3071.3071","article-title":"WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia","volume":"84","author":"Inoue","year":"1994","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jgo.2023.101582_bb0095","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1182\/blood.V90.3.1217","article-title":"High levels of Wilms\u2019 tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome","volume":"90","author":"Bergmann","year":"1997","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jgo.2023.101582_bb0100","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/sim.4780080504","article-title":"Flexible regression models with cubic splines","volume":"8","author":"Durrleman","year":"1989","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.jgo.2023.101582_bb0105","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"issue":"6","key":"10.1016\/j.jgo.2023.101582_bb0110","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making: Int J Soc Med Decis Making"},{"issue":"4","key":"10.1016\/j.jgo.2023.101582_bb0115","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jgo.2023.101582_bb0120","series-title":"Computing RFfS. R: a language and environment for statistical computing. Vienna, Austria","author":"Team RC","year":"2016"},{"issue":"3","key":"10.1016\/j.jgo.2023.101582_bb0125","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jgo.2023.101582_bb0130","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/leu.2014.234","article-title":"Comorbidity and performance status in acute myeloid leukemia patients: a nation-wide population-based cohort study","volume":"29","author":"\u00d8stg\u00e5rd","year":"2015","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.jgo.2023.101582_bb0135","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1182\/blood.V98.5.1302","article-title":"Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial","volume":"98","author":"Goldstone","year":"2001","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jgo.2023.101582_bb0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2018-08-868752","article-title":"Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia","volume":"133","author":"DiNardo","year":"2019","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jgo.2023.101582_bb0145","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and Venetoclax in previously untreated acute myeloid leukemia","volume":"383","author":"DiNardo","year":"2020","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.jgo.2023.101582_bb0150","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.18.01600","article-title":"Venetoclax combined with low-dose cytarabine for previously untreated patients with acute myeloid leukemia: results from a phase Ib\/II study","volume":"37","author":"Wei","year":"2019","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jgo.2023.101582_bb0155","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41375-018-0312-9","article-title":"Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome","volume":"33","author":"Cortes","year":"2019","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.jgo.2023.101582_bb0160","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1200\/JCO.20.01632","article-title":"Mutant isocitrate dehydrogenase 1 inhibitor ivosidenib in combination with azacitidine for newly diagnosed acute myeloid leukemia","volume":"39","author":"DiNardo","year":"2021","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jgo.2023.101582_bb0165","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00277-013-2001-0","article-title":"The G8 screening tool detects relevant geriatric impairments and predicts survival in elderly patients with a haematological malignancy","volume":"93","author":"Hamaker","year":"2014","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.jgo.2023.101582_bb0170","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/bjh.13319","article-title":"Prognostic significance of the medical research council cytogenetic classification compared with the European LeukaemiaNet risk classification system in acute myeloid leukaemia","volume":"170","author":"Kadia","year":"2015","journal-title":"Br J Haematol"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406823001790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406823001790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T03:46:09Z","timestamp":1745466369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406823001790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1879406823001790"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2023.101582","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic significance of the Geriatric 8 score alone and included with genetic risk group in older adults with acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2023.101582","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101582"}}